Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

Maria Isabel Lapid, Pamela J. Atherton, Simon Kung, Andrea L Cheville, Molly McNiven, Jeff A Sloan, Matthew M Clark, Teresa A. Rummans

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Cancer treatment can profoundly impact the patient's quality of life (QOL). It has been well documented that there are gender differences in the symptoms associated with cancer treatment. This study explores the impact of gender on QOL for patients with newly diagnosed advanced cancer. Methods: A randomized, controlled clinical trial in patients receiving radiotherapy for advanced cancer demonstrated maintenance of QOL with a six session multidisciplinary structured intervention compared to controls. This current study reports the gender differences in that trial. Outcome measures included the functional assessment of cancer therapy-general (FACT-G), linear analog self-assessment (LASA), and profile of mood states (POMS) at baseline and weeks 4, 27, and 52. Kruskal-Wallis was used to compare QOL scores. Results: One hundred thirty-one patients (45 women and 86 men, mean age 58.7) participated in the clinical trial. At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue-inertia subscale, and POMS confusion-bewilderment subscale (p < 0.05). Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02). At week 27, the only gender difference was that intervention group men had more POMS anger-hostility (p = 0.009). By week 52, there were no statistically significant gender differences in any of the QOL measures. Conclusions: Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, suggesting that early interventions can be tailored for each gender.

Original languageEnglish (US)
Pages (from-to)2485-2490
Number of pages6
JournalSupportive Care in Cancer
Volume21
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Quality of Life
Neoplasms
Confusion
Fatigue
Therapeutics
Hostility
Second Primary Neoplasms
Anger
Radiotherapy
Randomized Controlled Trials
Maintenance
Outcome Assessment (Health Care)
Clinical Trials
Self-Assessment

Keywords

  • Men
  • Oncology
  • Psychosocial
  • Radiation therapy
  • Well-being
  • Women

ASJC Scopus subject areas

  • Oncology

Cite this

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer? / Lapid, Maria Isabel; Atherton, Pamela J.; Kung, Simon; Cheville, Andrea L; McNiven, Molly; Sloan, Jeff A; Clark, Matthew M; Rummans, Teresa A.

In: Supportive Care in Cancer, Vol. 21, No. 9, 09.2013, p. 2485-2490.

Research output: Contribution to journalArticle

@article{cbc4e7e49c9848489613e799416b0e8a,
title = "Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?",
abstract = "Purpose: Cancer treatment can profoundly impact the patient's quality of life (QOL). It has been well documented that there are gender differences in the symptoms associated with cancer treatment. This study explores the impact of gender on QOL for patients with newly diagnosed advanced cancer. Methods: A randomized, controlled clinical trial in patients receiving radiotherapy for advanced cancer demonstrated maintenance of QOL with a six session multidisciplinary structured intervention compared to controls. This current study reports the gender differences in that trial. Outcome measures included the functional assessment of cancer therapy-general (FACT-G), linear analog self-assessment (LASA), and profile of mood states (POMS) at baseline and weeks 4, 27, and 52. Kruskal-Wallis was used to compare QOL scores. Results: One hundred thirty-one patients (45 women and 86 men, mean age 58.7) participated in the clinical trial. At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue-inertia subscale, and POMS confusion-bewilderment subscale (p < 0.05). Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02). At week 27, the only gender difference was that intervention group men had more POMS anger-hostility (p = 0.009). By week 52, there were no statistically significant gender differences in any of the QOL measures. Conclusions: Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, suggesting that early interventions can be tailored for each gender.",
keywords = "Men, Oncology, Psychosocial, Radiation therapy, Well-being, Women",
author = "Lapid, {Maria Isabel} and Atherton, {Pamela J.} and Simon Kung and Cheville, {Andrea L} and Molly McNiven and Sloan, {Jeff A} and Clark, {Matthew M} and Rummans, {Teresa A.}",
year = "2013",
month = "9",
doi = "10.1007/s00520-013-1825-4",
language = "English (US)",
volume = "21",
pages = "2485--2490",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

AU - Lapid, Maria Isabel

AU - Atherton, Pamela J.

AU - Kung, Simon

AU - Cheville, Andrea L

AU - McNiven, Molly

AU - Sloan, Jeff A

AU - Clark, Matthew M

AU - Rummans, Teresa A.

PY - 2013/9

Y1 - 2013/9

N2 - Purpose: Cancer treatment can profoundly impact the patient's quality of life (QOL). It has been well documented that there are gender differences in the symptoms associated with cancer treatment. This study explores the impact of gender on QOL for patients with newly diagnosed advanced cancer. Methods: A randomized, controlled clinical trial in patients receiving radiotherapy for advanced cancer demonstrated maintenance of QOL with a six session multidisciplinary structured intervention compared to controls. This current study reports the gender differences in that trial. Outcome measures included the functional assessment of cancer therapy-general (FACT-G), linear analog self-assessment (LASA), and profile of mood states (POMS) at baseline and weeks 4, 27, and 52. Kruskal-Wallis was used to compare QOL scores. Results: One hundred thirty-one patients (45 women and 86 men, mean age 58.7) participated in the clinical trial. At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue-inertia subscale, and POMS confusion-bewilderment subscale (p < 0.05). Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02). At week 27, the only gender difference was that intervention group men had more POMS anger-hostility (p = 0.009). By week 52, there were no statistically significant gender differences in any of the QOL measures. Conclusions: Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, suggesting that early interventions can be tailored for each gender.

AB - Purpose: Cancer treatment can profoundly impact the patient's quality of life (QOL). It has been well documented that there are gender differences in the symptoms associated with cancer treatment. This study explores the impact of gender on QOL for patients with newly diagnosed advanced cancer. Methods: A randomized, controlled clinical trial in patients receiving radiotherapy for advanced cancer demonstrated maintenance of QOL with a six session multidisciplinary structured intervention compared to controls. This current study reports the gender differences in that trial. Outcome measures included the functional assessment of cancer therapy-general (FACT-G), linear analog self-assessment (LASA), and profile of mood states (POMS) at baseline and weeks 4, 27, and 52. Kruskal-Wallis was used to compare QOL scores. Results: One hundred thirty-one patients (45 women and 86 men, mean age 58.7) participated in the clinical trial. At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue-inertia subscale, and POMS confusion-bewilderment subscale (p < 0.05). Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02). At week 27, the only gender difference was that intervention group men had more POMS anger-hostility (p = 0.009). By week 52, there were no statistically significant gender differences in any of the QOL measures. Conclusions: Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, suggesting that early interventions can be tailored for each gender.

KW - Men

KW - Oncology

KW - Psychosocial

KW - Radiation therapy

KW - Well-being

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=84881250802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881250802&partnerID=8YFLogxK

U2 - 10.1007/s00520-013-1825-4

DO - 10.1007/s00520-013-1825-4

M3 - Article

C2 - 23609927

AN - SCOPUS:84881250802

VL - 21

SP - 2485

EP - 2490

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 9

ER -